Research

Dresser follows in Giacomini’s footsteps as an advocate for DEI in science and industry

Fri Apr 15, 2022

Mark Dresser, PhD ’00

Dresser is the first openly-LGBTQ president of the ASCPT

2022 Koda-Kimble Seed Awards fuel the School’s most innovative ideas

Tue Apr 5, 2022

Elisabeth Fall

Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy

This year’s Seed Awards will support projects ranging from the discovery sciences and patient care to sustainability and diversity, equity, and inclusion

UCSF School of Pharmacy leads in NIH funding for the 42nd straight year

Tue Feb 15, 2022

Susan Merrell

Nadav Ahituv, PhD (right), works in his lab with postdoctoral researcher Fumitaka Inoue, PhD.

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school for the 42nd consecutive year.

Researchers pioneer new method to edit genes in human cells

Thu Jan 6, 2022

Shipman lab pioneers more efficient genome editing

Wed Jan 5, 2022

Seth Shipman, PhD, left, and Santiago C. Lopez in discussion in the laboratory. The two led the lab’s recent work pioneering an improved method for genome editing across the kingdoms of life.

Recent findings from the laboratory of Seth Shipman, PhD, show that a type of bacterial DNA known as a retron can be harnessed to dramatically improve genome editing.

Beyond the spike protein

Mon Jan 3, 2022

NIAID/NIH

A human cell (green) infected with SARS-CoV-2 virus particles (purple). Research from QBI has identified how the Alpha variant of the virus evades the human immune system.

Findings from QBI point to a host of viral proteins that enable SARS-CoV-2 variants to evade the immune system.

UCSF researchers develop a new drug regimen to combat malaria in children

Thu Dec 16, 2021

Child sitting on a bed surrounded by a bed net

UK Department for International Development

A child sits on a bed surrounded by a bed net intended to prevent mosquito bites that could transmit malaria, Kenya. A new drug regimen developed at UCSF offers children improved protection against the disease.

Study shows that monthly doses of two common anti-malarial drugs for the first few years of life can provide 95 percent protection against the disease.

Five School of Pharmacy trainees earn honors from the American Society for Clinical Pharmacology & Therapeutics

Tue Dec 14, 2021

Wikimedia Commons

PhD students and postdoctoral researchers earn the 2022 Presidential Trainee Award

Map of protein systems reveals new targets for cancer treatment

Thu Dec 9, 2021

Krogan Lab

A birds-eye depiction of the findings from the Quantitative Biosciences Institute’s recent work on cancer. Each node represents a protein system and darker-colored nodes are more likely to be involved in cancer.

Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head

Burchard delivers Faculty Research Lecture in Clinical Science

Mon Nov 15, 2021